Skip to content
The Policy VaultThe Policy Vault

lidocaine 5% patches — Medical Mutual

Diabetic Peripheral Neuropathy (DPN)

Initial criteria

  • Diagnosis of diabetic peripheral neuropathy (DPN)

Reauthorization criteria

  • Response to therapy required for continuation

Approval duration

2 years